Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Kumari, Shiwania; 1 | Singh, Ambicab; 1 | Singh, Abhinay Kumara | Yadav, Yudhishthira | Bajpai, Swatib | Kumar, Pramodb | Upadhyay, Ashish Dattc | Shekhar, Shashanka | Dwivedi, Sadanandc | Dey, A.B.b | Dey, Sharmisthaa; *
Affiliations: [a] Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India | [b] Department of Geriatric Medicine, All India Institute of Medical Sciences, New Delhi, India | [c] Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India
Correspondence: [*] Correspondence to: Dr. Sharmistha Dey, Department of Biophysics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India. Tel.: +91 11 2659 6435; Fax: +91 11 2658 8663; E-mail: [email protected].
Note: [1] These authors contributed equally to this work.
Abstract: Background:Alzheimer’s disease (AD) is the progressive brain disorder which degenerates brain cells connection and causes memory loss. Although AD is irreversible, it is not impossible to arrest or slow down the progression of the disease. However, this would only be possible if the disease is diagnosed at an early stage, and early diagnosis requires clear understanding of the pathogenesis at molecular level. Overactivity of GSK-3β and p53 accounts for tau hyperphosphorylation and the formation of amyloid-β plaques. Objective:Here, we explored GSK-3β and p53 as blood-based biomarkers for early detection of AD. Methods:The levels of GSK-3β, p53, and their phosphorylated states were measured using surface plasmon resonance and verified using western blot in serum from AD, mild cognitive impairment (MCI), and geriatric-control (GC) subjects. The neurotoxic SH-SY5Y cell line was treated with antioxidant Emblica Officinalis (EO) for rescue effect. Results:GSK-3β, p53, and their phosphorylated states were significantly over expressed (p > 0.001) in AD and MCI compared to GC and can differentiate AD and MCI from GC. The expression level of GSK-3β and p53 proteins were found to be downregulated in a dose-dependent manner after the treatment with EO in amyloid-b-induced neurotoxic cells. Conclusion:These proteins can serve as potential blood markers for the diagnosis of AD and EO can suppress their level. This work has translational value and clinical utility in the future.
Keywords: Alzheimer’s disease, Emblica Officinalis, GSK-3β, mild cognitive impairment, protein biomarker, SH-SY5Y , surface plasmon resonance
DOI: 10.3233/JAD-215347
Journal: Journal of Alzheimer's Disease, vol. 85, no. 1, pp. 249-260, 2022
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]